Immune response during and after reactive hemophagocytic lymphohistiocytosis (HLH)

Immune response during and after reactive hemophagocytic lymphohistiocytosis (HLH) - Immune Response in HLH

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON48155

Enrollment

Registered

2020-03-17

Start date

2020-04-06

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macrophage Activation Syndrome (MAS)

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Hemophagocytic lymphohistiocytosis (HLH) secondary to infection

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Immune reponse Genetic variants	—

Secondary

Measure	Time frame
Characterisation of the patient population.	—

Countries

Netherlands

Outcome results